Supplementary Figure from Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity

Authors :: Matthew J. Walters
Kelsey E. Sivick
Uli Schindler
Jay P. Powers
Stephen W. Young
Jaroslaw Kalisiak
Nikki Kimura
Timothy W. Park
Bhamini Purandare
Susan L. Paprcka
Fangfang Yin
Akshata R. Udyavar
Elaine Ginn
Ada Chen
Kristen Zhang
Daniel DiRenzo
Nell Narasappa
Jesus Banuelos
Annette Becker
Joanne B.L. Tan
Dana Piovesan
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure from Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity

Full Text Access

Tools